S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
pixel
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
pixel
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
pixel
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
pixel
pixel
Log in
NASDAQ:ALXN

Alexion Pharmaceuticals SEC Filings & 10K Form

$158.71
+2.01 (+1.28 %)
(As of 01/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$158.11
Now: $158.71
$159.40
50-Day Range
$117.74
MA: $146.74
$158.03
52-Week Range
$72.67
Now: $158.71
$160.03
Volume4.25 million shs
Average Volume3.33 million shs
Market Capitalization$34.73 billion
P/E Ratio37.08
Dividend YieldN/A
Beta1.33

SEC Filings

Alexion Pharmaceuticals (NASDAQ:ALXN) SEC Filings

DateFilerForm TypeView
01/14/2021
4:11 PM
Alexion Pharmaceuticals (Subject)
Form 425
01/12/2021
6:17 AM
Alexion Pharmaceuticals (Subject)
Form 425
01/12/2021
6:14 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2020
4:12 PM
Alexion Pharmaceuticals (Issuer)
HANTSON LUDWIG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
4:10 PM
Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
4:09 PM
Alexion Pharmaceuticals (Issuer)
Goff Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
4:08 PM
Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
4:07 PM
Alexion Pharmaceuticals (Subject)
Form 425
12/18/2020
4:06 PM
Alexion Pharmaceuticals (Issuer)
ORLOFF JOHN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
1:32 PM
Alexion Pharmaceuticals (Subject)
ASTRAZENECA PLC (Filed by)
Form 425
12/17/2020
4:07 PM
Alexion Pharmaceuticals (Subject)
Form 425
12/17/2020
4:05 PM
Alexion Pharmaceuticals (Subject)
Form 425
12/17/2020
10:35 AM
Alexion Pharmaceuticals (Subject)
ASTRAZENECA PLC (Filed by)
Form 425
12/15/2020
2:55 PM
Alexion Pharmaceuticals (Subject)
ASTRAZENECA PLC (Filed by)
Form 425
12/14/2020
4:14 PM
Alexion Pharmaceuticals (Subject)
Form 425
12/14/2020
3:58 PM
Alexion Pharmaceuticals (Subject)
ASTRAZENECA PLC (Filed by)
Form 425
12/14/2020
3:57 PM
Alexion Pharmaceuticals (Subject)
ASTRAZENECA PLC (Filed by)
Form 425
12/14/2020
2:55 PM
Alexion Pharmaceuticals (Subject)
ASTRAZENECA PLC (Filed by)
Form 425
12/14/2020
8:23 AM
Alexion Pharmaceuticals (Subject)
Form 425
12/14/2020
8:21 AM
Alexion Pharmaceuticals (Subject)
Form 425
12/14/2020
8:19 AM
Alexion Pharmaceuticals (Subject)
Form 425
12/14/2020
8:05 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2020
3:47 PM
Alexion Pharmaceuticals (Issuer)
Carino Tanisha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2020
4:17 PM
Alexion Pharmaceuticals (Issuer)
SARIN ARADHANA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2020
6:13 AM
Alexion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2020
5:49 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2020
4:02 PM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2020
7:22 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2020
6:38 AM
Alexion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2020
6:06 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2020
5:11 PM
Alexion Pharmaceuticals (Reporting)
Inozyme Pharma, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2020
8:34 PM
Alexion Pharmaceuticals (Reporting)
Inozyme Pharma, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/02/2020
7:53 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2020
5:03 AM
Alexion Pharmaceuticals (Filed by)
PORTOLA PHARMACEUTICALS INC (Subject)
Form SC TO-T/A
06/25/2020
8:27 AM
Alexion Pharmaceuticals (Filed by)
PORTOLA PHARMACEUTICALS INC (Subject)
Form SC TO-T/A
06/24/2020
4:01 PM
Alexion Pharmaceuticals (Filed by)
PORTOLA PHARMACEUTICALS INC (Subject)
Form SC TO-T/A
06/15/2020
7:30 AM
Alexion Pharmaceuticals (Filed by)
PORTOLA PHARMACEUTICALS INC (Subject)
Form SC TO-T/A
06/09/2020
4:05 PM
Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2020
4:01 PM
Alexion Pharmaceuticals (Issuer)
LAW ANNE-MARIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2020
3:59 PM
Alexion Pharmaceuticals (Issuer)
ORLOFF JOHN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2020
3:58 PM
Alexion Pharmaceuticals (Issuer)
Goff Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
4:23 PM
Alexion Pharmaceuticals (Filed by)
PORTOLA PHARMACEUTICALS INC (Subject)
Form SC TO-T/A
06/03/2020
4:23 PM
Alexion Pharmaceuticals (Filer)
Form 8-K/A
06/01/2020
3:35 PM
Alexion Pharmaceuticals (Filed by)
PORTOLA PHARMACEUTICALS INC (Subject)
Form SC TO-T/A
05/27/2020
7:01 AM
Alexion Pharmaceuticals (Filed by)
PORTOLA PHARMACEUTICALS INC (Subject)
Form SC TO-T
05/19/2020
3:56 PM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2020
5:57 PM
667, L.P. (Reporting)
Alexion Pharmaceuticals (Issuer)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
4:22 PM
Alexion Pharmaceuticals (Issuer)
Brennan David R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
4:20 PM
Alexion Pharmaceuticals (Issuer)
Rummelt Andreas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
4:18 PM
Alexion Pharmaceuticals (Issuer)
Mollen John T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
4:17 PM
Alexion Pharmaceuticals (Issuer)
Reinsdorf Judith A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
4:15 PM
Alexion Pharmaceuticals (Issuer)
COUGHLIN CHRISTOPHER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
4:14 PM
Alexion Pharmaceuticals (Issuer)
Nader Francois (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
4:12 PM
Alexion Pharmaceuticals (Issuer)
FRIEDMAN PAUL A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
4:10 PM
Alexion Pharmaceuticals (Issuer)
Dunsire Deborah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2020
3:31 PM
Alexion Pharmaceuticals (Filed by)
PORTOLA PHARMACEUTICALS INC (Subject)
Form SC TO-C
05/06/2020
6:23 AM
Alexion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2020
5:54 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2020
8:30 PM
Alexion Pharmaceuticals (Filed by)
PORTOLA PHARMACEUTICALS INC (Subject)
Form SC TO-C
05/05/2020
4:05 PM
Alexion Pharmaceuticals (Filed by)
PORTOLA PHARMACEUTICALS INC (Subject)
Form SC TO-C
05/05/2020
6:19 AM
Alexion Pharmaceuticals (Filed by)
PORTOLA PHARMACEUTICALS INC (Subject)
Form SC TO-C
05/05/2020
6:17 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2020
4:26 PM
Alexion Pharmaceuticals (Filer)
Form DEFA14A
04/06/2020
12:25 PM
Alexion Pharmaceuticals (Filer)
Form CT ORDER
03/31/2020
4:04 PM
Alexion Pharmaceuticals (Issuer)
HANTSON LUDWIG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2020
5:46 PM
667, L.P. (Reporting)
Alexion Pharmaceuticals (Issuer)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2020
5:45 PM
667, L.P. (Reporting)
Alexion Pharmaceuticals (Issuer)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
5:31 PM
Alexion Pharmaceuticals (Issuer)
Chiniara Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
5:30 PM
Alexion Pharmaceuticals (Issuer)
HANTSON LUDWIG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
5:28 PM
Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
5:26 PM
Alexion Pharmaceuticals (Issuer)
ORLOFF JOHN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
5:23 PM
Alexion Pharmaceuticals (Issuer)
Carino Tanisha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
5:21 PM
Alexion Pharmaceuticals (Issuer)
LAW ANNE-MARIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
5:20 PM
Alexion Pharmaceuticals (Issuer)
SARIN ARADHANA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
5:18 PM
Alexion Pharmaceuticals (Issuer)
Goff Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
5:16 PM
Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
9:53 AM
Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
9:36 AM
Alexion Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/12/2020
10:01 AM
Alexion Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/10/2020
4:00 PM
Alexion Pharmaceuticals (Issuer)
HANTSON LUDWIG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
3:58 PM
Alexion Pharmaceuticals (Issuer)
Goff Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
3:57 PM
Alexion Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
3:56 PM
Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
5:30 AM
Alexion Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/30/2020
5:34 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2020
8:47 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
5:18 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2020
9:25 AM
Alexion Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
12/04/2019
5:52 PM
Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
5:38 PM
Alexion Pharmaceuticals (Issuer)
Bazarko Daniel (Reporting)
Form 3/A
12/04/2019
5:36 PM
Alexion Pharmaceuticals (Issuer)
SARIN ARADHANA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2019
3:37 PM
Alexion Pharmaceuticals (Issuer)
Carino Tanisha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
3:44 PM
Alexion Pharmaceuticals (Issuer)
Carino Tanisha (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2019
6:56 AM
Alexion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/23/2019
6:13 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2019
4:27 PM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2019
7:53 AM
Alexion Pharmaceuticals (Filer)
Form DEFA14A
10/16/2019
7:50 AM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2019
3:12 PM
Alexion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2019
7:00 AM
Alexion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
This page was last updated on 1/20/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.